Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221133

Medchemexpress LLC Jqad1 | 2417097-18-6 | 98.2% | 932.95 | C48H52F4N6O9 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1457655MG

Encompass_Preferred

JQAD1 is a CRBN-dependent proteolysis-targeting chimera (PROTAC) that selectively targets the histone acetyltransferase EP300 for degradation. It suppresses EP300 expression, reduces H3K27ac modification, and can induce apoptosis in cellular models, making it suitable as a research reagent for studying EP300 function and target validation.

  • Selective EP300 degradation in cell-based assays.
  • CRBN-dependent PROTAC mechanism of action.
  • Reduces H3K27ac histone modification associated with EP300 activity.
  • Reported high purity suitable for biological research.
  • Available in small quantities for experimental screening and validation.

Catalog No. 50-002-21133


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.